Pharmaceutical Needs Assessment
The Health and Wellbeing Board (HWB) has a duty to produce a Pharmaceutical Needs Assessment (PNA) every 3 years. PNAs include:
- A statement of the pharmaceutical services provided that are necessary to meet needs in the area;
- A statement of the pharmaceutical services that have been identified by the HWB that are needed in the area, and are not provided (gaps in provision);
- A statement of the other services which are provided, which are not needed, but which have secured improvements or better access to pharmaceutical services in the area;
- A statement of the services that the HWB has identified as not being provided, but which would, if they were to be provided, secure improvements or better access to pharmaceutical services in the area;
- A statement of other NHS services provided by a local authority, the NHS Commissioning Board (NHS England), a Clinical Commissioning Group (CCG) or an NHS Trust, which affect the needs for pharmaceutical services;
- An explanation of how the assessment has been carried out (including how the consultation was carried out); and
- A map of providers of pharmaceutical services.
The Department of Health and Social Care (DHSC) has determined that the requirement to publish renewed Pharmaceutical Needs Assessments (PNAs) will be suspended for a year in order to reduce unnecessary extra pressure on local authorities and local pharmaceutical committees during the response to the Covid-19 pandemic.
DHSC's announcement means that renewed PNAs will not need to be published until April 2022 but Health and Wellbeing Boards will retain the ability to issue supplementary statements to respond to local changes and pharmaceutical needs during this time.
View the Bury Local Authority Pharmaceutical Needs Assessment (Draft version for consultation)